Glycopyrrolate
Dose: 3 to 8 mcg/kg/dose IV, IM
|
Comments: Glycopyrrolate is an anticholinergic drug that decreases tracheobronchial and pharyngeal secretions, decrease the volume and acidity of gastric secretions, and counteracts interoperative vagally mediated arrhythmias. It can also be used to block arrhythmias and excessive secretions due to neostigmine administration when it is used to reverse neuromuscular blockade. It does not easily cross the blood-brain barrier, like atropine and scopolamine, so it has less CNS side effects. Glycopyrrolate contains benzyl alcohol, 0.9% as a preservative. More comments on glycopyrrolate. |
| Toxicity: Adverse effects of glycopyrrolate are extensions of its pharmacological effects. These include tachycardia, dry mouth, urinary retention, nausea vomiting, constipation, headache, dizziness, and blurred vision (Facts and Comparisons, Inc. Drug Facts and Comparisons. Olin, B.R. ed. St. Louis, MO:Facts and Comparisons, Inc; 1997, page 298). |
Preparation: Glycopyrrolate (Robinol) is
available in a 1 or 2 ml vials with a concentration of 0.2 mg/ml..
|
Compatibility: No information available on filter or TPN. It is compatible with D5W, D10W, D5NS, D10NS, NS, LR, atropine, fentanyl, lidocaine, midazolam, morphine, propofol, and ranitidine. It is incompatible with chloramphenicol, dexamethasone, diazepam, and sodium bicarbonate. Do not mix with fluids with a pH greater than 6 such as a barbiturates. |
Weight (grams) |
Dose (ml) |
Weight (grams) |
Dose (ml) |
500 |
* |
3000 |
0.45 |
750 |
0.11 |
3250 |
0.49 |
1000 |
0.15 |
3500 |
0.53 |
1250 |
0.19 |
3750 |
0.56 |
1500 |
0.23 |
4000 |
0.60 |
1750 |
0.26 |
4250 |
0.64 |
2000 |
0.30 |
4500 |
0.68 |
2250 |
0.34 |
4750 |
0.71 |
2500 |
0.38 |
5000 |
0.75 |
2750 |
0.41 |
5250 |
0.79 |
* For small doses, add 9 ml of saline to
1 ml of the glycopyrrolate 20 mcg/ml dilution. This gives a
concentration of 2 mcg/ml. The dose in mls would be:
3 mcg/kg X Wgt (kg) / 2 mcg/ml.
We use the undiluted parenteral dosage form which is 200 mcg/ml via whatever enteral route...I would think this would be OK for nasojejunal use as well as PO or intragastric. Again the concentration is for PO is 10 x the parenteral concentration. Makes the dose volumes turn out the same, but still potentially problem prone